Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-01-05 @ 6:01 PM
Study NCT ID:
NCT00991250
Status:
UNKNOWN
Last Update Posted:
2010-02-05
First Post:
2009-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma
Sponsor:
SentoClone AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Mel-Swe-01 2009-12-17
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Freddi Lewin, Medical director
Old Organization:
SentoClone AB